US20050149116A1 - Systems and methods for sealing a vascular puncture - Google Patents

Abstract

Systems and methods introduce a closure material to seal a vessel puncture site. The system and methods provide a catheter adapted for passage through a tissue puncture and sized to occupy substantially all the tissue puncture. The catheter includes a lumen in fluid communication with a fluid delivery port adjacent the catheter distal end. One or more dispensers are in fluid communication with the catheter lumen for dispensing first and second fluid compositions in the catheter lumen. An actuator causes the first and second fluid compositions to be dispensed from the dispensers and mixed by flowing the first and second fluid compositions through a static mixer. The first and second fluid compositions are dispensed from the fluid delivery port as a fluid mixture that reacts in situ to form a nonfluent closure composition adjacent the vessel puncture site.

Description

RELATED APPLICATIONS
• This application is a continuation of co-pending U.S. Application. Ser. No. 10/406,017, filed Apr. 3, 2003, which is a divisional of U.S. application Ser. No. 10/132,848, filed Apr. 23, 2002, now U.S. Pat. No. 6,562,059, which is a divisional of U.S. application Ser. No. 09/334,300, filed Jun. 16, 1999, now abandoned, which is a continuation of U.S. application Ser. No. 08/963,408, filed Nov. 3, 1997, now U.S. Pat. No. 6,033,401, which claims the benefit of Provisional U.S. Application Ser. No. 60/036,299, filed Mar. 12, 1997, entitled “Universal Introducer.”
FIELD OF THE INVENTION
• This invention relates to a vessel closure device, and more particularly to a device for effecting the closure of a vessel by delivering a fluent closure composition precursor and converting the composition in situ to a non-fluent closure composition.
BACKGROUND OF THE INVENTION
• A wide variety of surgical procedures are performed by the introduction of a catheter into a vessel. After the surgical procedure is completed, closure of the vessel at the site where the catheter was introduced is needed. Vessel punctures formed in the process of performing a catheter based surgical procedure are commonly 1.5 mm to 7.0 mm in diameter and can be larger. Closure of these punctures is frequently complicated by anticoagulation medicine given to the patient which interferes with the body's natural clotting abilities.
• Closure of a vessel puncture has traditionally been performed by applying pressure to the vessel adjacent the puncture site. This procedure requires the continuous attention of at least one medical staff member to apply pressure to the vessel puncture site and can take as long as 30 minutes.
• Devices have been developed for effecting the closure of vessel punctures through the application of energy. See U.S. Pat. Nos. 5,626,601; 5,507,744; 5,415,657; and 5,002,051. Devices have also been developed for effecting the closure of vessel punctures through the delivery of a mechanical mechanism which mechanically seals the puncture. See U.S. Pat. Nos. 5,441,520; 5,441,517; 5,306,254; 5,282,827; and 5,222,974. Devices have also been developed for effecting the closure of vessel punctures through the delivery of a composition to block the vessel puncture. See U.S. Pat. Nos. 5,601,602; 5,591,205; 5,441,517; 5,292,332; 5,275,616; 5,192,300; and 5,156,613. Despite the various devices that have been developed for closing vessel punctures, a need still exists for a simple, safe and inexpensive device and method for closing vessel punctures.
SUMMARY OF THE INVENTION
• One aspect of the invention provides an assembly for introducing a closure material to seal a vessel puncture site. The closure material comprises a mixture of a first and second fluid composition which, upon mixing, react to form a nonfluent closure composition. The assembly comprises a catheter sized and configured for passage through a tissue puncture. The catheter has at least one fluid delivery port adjacent the catheter distal end and adapted to occupy a position adjacent the vessel puncture site. The catheter includes a lumen that is in fluid communication with the fluid delivery port. One or more dispensers are provided in fluid communication with the catheter lumen for dispensing the first and second fluid compositions in the catheter lumen. An actuator is provided for causing the first and second fluid compositions to be dispensed from the one or more dispensers and mixed by flowing the first and second fluid compositions through a static mixer. The first and second fluid compositions are dispensed from the fluid delivery port as a fluid mixture that reacts in situ to form the nonfluent closure composition adjacent the vessel puncture site. The catheter is sized to block flow of the fluid mixture from the fluid delivery port into a substantial part of the tissue puncture.
• In one embodiment, the static mixer is a cartridge. In another embodiment, the static mixer is incorporated into the catheter.
• Another aspect of the invention provides a method for sealing a vascular puncture site. A catheter is introduced through a tissue puncture. The catheter is sized to occupy substantially all the tissue puncture and includes at least one fluid delivery port adjacent the distal end of the catheter adapted to be positioned adjacent the vessel puncture site. First and second fluid compositions are provided which; upon mixing, react to form a nonfluent closure composition. The first and second fluid compositions are mixed by flowing the components through a static mixer that communicates with the fluid delivery port. The first and second fluid compositions are dispensed from the fluid delivery port as a fluid mixture that reacts in situ to form the nonfluent closure composition adjacent the vessel puncture site. The size of the catheter blocks flow of the fluid mixture from the fluid delivery port into a substantial part of the tissue puncture, whereby a localized in situ closure forms adjacent the vessel puncture site to seal the vessel puncture site.
• In one embodiment, the static mixer is a cartridge. In another embodiment, the static mixer is incorporated into the catheter.
BRIEF DESCRIPTION OF THE DRAWINGS
• FIG. 1A is a side view of a closure device according to the present invention.
• FIG. 1B is a cross section of the closure device ofFIG. 1A.
• FIG. 2 is a cross section of a closure device with a first and second closure lumen coupled to first and second closure composition precursor sources.
• FIG. 3A is a side view of a closure device including a guidewire lumen configured to accommodate a guidewire.
• FIG. 3B is a cross section of a closure device illustrated inFIG. 3A.
• FIG. 4A illustrates a sheath with a distal end disposed within a vessel.
• FIG. 4B illustrates a closure device disposed within the sheath such that the distal end of the closure device extends beyond the distal end of the sheath.
• FIG. 4C illustrates the sheath and closure device withdrawn from the vessel until the position sensing mechanism is located outside the vessel adjacent the puncture.
• FIG. 4D illustrates a closure composition precursor source coupled to the closure device ofFIG. 4C. The closure composition precursor is delivered through the closure lumen to the puncture.
• FIG. 4E illustrates the puncture after the closure device ofFIG. 4D is withdrawn from the puncture.
• FIG. 4F illustrates the puncture after the closure device is completely withdrawn from the tissue site.
• FIG. 5A is a side view of a locking mechanism coupled to a closure device and threads on a sheath.
• FIG. 5B is a side view of the locking mechanism ofFIG. 5A coupled to the threads on a sheath.
• FIG. 6A illustrates a sheath with a distal end disposed within a vessel.
• FIG. 6B illustrates a guidewire disposed within the sheath ofFIG. 6A.
• FIG. 6C illustrates the sheath ofFIG. 6B withdrawn along the guidewire.
• FIG. 6D illustrates a closure device threaded along the guidewire ofFIG. 6C until the distal end of the device is disposed within a vessel.
• FIG. 6E illustrates the closure device ofFIG. 6D after the guidewire has been withdrawn. The closure device is withdrawn until the position sensing mechanism is located outside the vessel adjacent the puncture.
• FIG. 6F illustrates a closure composition precursor source coupled to the closure device ofFIG. 6E. The closure composition precursor is delivered through the closure lumen to the puncture.
• FIG. 6G illustrates the puncture after the closure device is completely withdrawn from the tissue site.
• FIG. 7A is a side view of a closure device including a fiber optic ring as a energy delivery device.
• FIG. 7B is a cross section of the fiber optic ring ofFIG. 7A.
• FIG. 8A is a side view of a closure device with a contact switch as a position sensing mechanism.
• FIG. 8B is a side view of a contact switch ofFIG. 8A being compressed by the vessel wall.
• FIG. 9A is a cross section of a closure device containing a plurality of precursor exit ports coupled to a single closure lumen.
• FIG. 9B is a cross section of a closure device containing a plurality of precursor exit ports coupled to a plurality of closure lumens.
• FIG. 9C illustrates a closure device with a plurality of pressure ports and first and second closure lumens.
• FIG. 10A is a side view of a closure device including a balloon as the position sensing device.
• FIG. 10B illustrates the closure device ofFIG. 10A disposed within a vessel.
• FIG. 11 illustrates a position sensing mechanism in the form of a curved wire positioned within the vessel lumen.
• FIG. 12A is a cross section of a closure device with a plurality of closure lumens and a static mixer.
• FIG. 12B is a cross section of a static mixer which is a removable cartridge.
• FIG. 13 is a cross section of a closure device which alternate the precursor exit ports from a first closure compound with the precursor exit ports of a second closure compound.
• FIG. 14A is a cross section of an anti-backflow valve.
• FIG. 14B is a cross section of an anti-backflow valve.
• FIG. 15A illustrates a flapper valve disposed within the distal end of a closure device.
• FIG. 15B is a side view of a flapper valve.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
• FIGS. 1A and 1B illustrate aclosure device10 according to the present invention. Theclosure device10 may be used to seal a puncture in a vessel such as a femoral artery.
• Theclosure device10 includes anelongated body12 with aproximal end14 and adistal end16 sized to be inserted into a lumen of a vessel. The surface of theelongated body12 is preferably made of a non-stick material, such as Teflon, or coated with a biocompatible lubricant. Positioned within theelongated body12 are one or more closure lumens which extend from adjacent theproximal end14 of the device to thedistal end16 of the device for introducing a closure composition precursor adjacent the vessel puncture site. Illustrated inFIGS. 1A and 1B is aclosure device10 with asingle closure lumen18 with aprecursor entrance port20 and at least oneprecursor exit port22 adjacent thedistal end16. Theprecursor entrance port20 is preferably removably coupleable to a closurecomposition precursor source24 for supplying the closure composition precursor to theclosure device10. Theclosure lumen18 may optionally contain ananti-backflow valve26 to prevent blood from flowing into theclosure lumen18 from the vessel.
• The closure composition precursor can be formed of one or more fluent materials that can be flowed from the closurecomposition precursor source24 to adjacent the devicedistal end16 through theclosure lumen18. The fluent closure composition precursor is transformed into a non-fluent closure composition in situ to effect closure of the puncture. In a preferred embodiment, energy is applied to the closure composition precursor to accelerate its transformation into the non-fluent closure composition. The transformation of the fluent precursor to a non-fluent closure composition may be the result of a phase change (i.e. solidification) of the precursor or a chemical modification of the precursor. For example, the precursor may be formed from multiple components which react with each other, optionally accelerated by a catalyst or energy. Alternatively, the precursor may be formed from a single component which reacts with itself, also optionally accelerated by a catalyst or energy.
• In embodiments where energy is applied, thebody12 includes anenergy delivery device28 adjacent thedistal end16. Theenergy delivery device28 may be designed to deliver one or more different types of energy including but not limited to electromagnetic radiation (RF, microwave, ultraviolet, visible light, laser), ultrasound, resistive heating, exothermic chemical heating, and frictional heating. The energy source may also function to withdraw energy, i.e., perform cooling. Theclosure device10 may also include an energysource attachment mechanism30 for placing theenergy delivery device28 in energetic communication with anenergy source32.
• Thebody12 further includes at least oneposition sensing mechanism34 adjacent thedistal end16 of theclosure device10 for indicating whether theposition sensing mechanism34 is located within or outside of thevessel36. Theposition sensing mechanism34 should be positioned on thebody12 distal to theprecursor exit port22 so that when theposition sensing mechanism34 is outside thevessel36 theprecursor exit port22 is also outside thevessel36.FIG. 1A illustrates theclosure device10 with a singleposition sensing mechanism34. As illustrated, theclosure device10 may also include a positionmonitor attachment port38 for coupling theposition sensing mechanism34 to aposition monitor40. Examples of a position sensing mechanisms include, but are not limited to, a pressure port and an electrical contact switch.
• Other sensors (not shown) may also be positioned on thebody12. For instance, a temperature sensor for measuring temperature adjacent thedistal end16 of thebody12 and/or an impedance sensor may be positioned at thedistal end16 of theclosure device10.
• Thebody12 can include two or more closure lumens for the introduction of closure composition precursor. For example, as illustrated inFIG. 2, asecond closure lumen42 may be coupled to a second closurecomposition precursor source44 by a secondprecursor entrance port46. Thesecond closure lumen42 may also contain ananti-backflow valve26 to prevent blood flow through thesecond closure lumen42.
• The closure composition precursor may be introduced adjacent the vessel puncture as a single composition through a single closure lumen. Alternately, a first composition may be introduced through theclosure lumen18 and a second composition can be introduced through thesecond closure lumen42, as illustrated inFIG. 2. The first and second compositions can be the same or different and can be introduced simultaneously or at different times. The first and second compositions may interact to accelerate the transformation to the non-fluent closure composition at thetissue site54, for example, by reacting with each other or by one catalyzing the solidification of the other.
• FIGS. 3A-3B illustrate another embodiment of the invention configured to be used with a guidewire. As illustrated inFIG. 3A, thebody12 can include aguidewire lumen48 configured to accommodate a guidewire. Theguidewire lumen48 can include an anti-backflow valve orhemostasis valve50.FIG. 3B illustrates a cross-section of the device illustrated inFIG. 3B.
• FIGS. 4A-4F illustrate a method of using theclosure device10 illustrated inFIGS. 1A-1B. Theclosure device10 is used after a surgical procedure where avessel36 such as a femoral artery has been punctured. Angioplasty is a typical surgery which results in puncturing the femoral artery with a catheter. After the catheter devices from such a surgical procedure have been removed, asheath52 typically remains within atissue site54 as illustrated inFIG. 4A. Thesheath52 penetrates theskin56 of the patient and passes through the underlying tissue to avessel60. Thedistal end16 of thesheath52 is positioned through apuncture62 in thevessel60.
• As illustrated inFIG. 4B, theclosure device10 is inserted into thesheath lumen64. The position of theclosure device10 within thesheath52 may be set by fixing theclosure device10 to the sheath. For example, as illustrated, theclosure device10 may include astop collar66 which may engage anupper flange68 on thesheath64. Thedistal end16 of theclosure device10 extends from thesheath52 such that theposition sensor30 andprecursor exit port22 are distal relative to thesheath52 and positioned within thevessel60.
• As illustrated inFIG. 4C, thesheath52 andclosure device10 are simultaneously withdrawn until theposition sensor30 is sensed to be located outside thevessel60. Since theprecursor exit port22 is positioned distal relative to theposition sensor30, theprecursor exit port22 is necessarily positioned outside thevessel60 when the position sensor is outside thevessel60.
• As illustrated inFIG. 4D, a fluentclosure composition precursor70 is delivered through theclosure lumen18 and out theprecursor exit port22 after theprecursor exit port22 is determined to be outside thevessel60. The fluentclosure composition precursor44 should have sufficiently low viscosity to allow the closure composition precursor to flow through theclosure lumen18. Once delivered, theclosure composition precursor44 accumulates adjacent thevessel60. The transformation of the closure composition precursor to a non-fluent closure composition serves to seal thevessel puncture62. Energy can optionally be delivered from theenergy delivery device28 to the closure composition precursor as illustrated byarrows72 in order to cause and/or accelerate transformation to the non-fluent closure composition. Alternatively or in addition, a catalyst can be added to catalyze the conversion of the fluent precursor to a non-fluent closure composition.
• FIG. 4E illustrates the withdrawal of theclosure device10.
• InFIG. 4F theclosure device10 is completely withdrawn from thetissue site54 and pressure is being applied at thearrows74 for a sufficient period of time after the closure composition precursor is delivered to allow the closure composition to transition to non-fluent closure composition.
• Thebody12 can optionally further include alocking mechanism76 for coupling theclosure device10 to thesheath52. For example, as illustrated inFIGS. 5A and 5B, thelocking mechanism76 can be a threadednut78 complementary tothreads80 at theproximal end14 of thesheath52. When theclosure device10 is positioned within thesheath52 the threadednut78 is turned to engage thethreads80 on thesheath52 as illustrated inFIG. 5B. As a result, thesheath52 andclosure device10 move as a unitary body. Movement as a unitary body is desirable to prevent theclosure device10 from moving relative to thesheath52 when theclosure device10 is withdrawn from thetissue site54. Other mechanisms can be used to lock the closure device to a sheath including, for example, straps, snap-fit arrangements, bayonet locks, magnets, adhesives, and detents.
• FIGS. 6A-6G illustrate a method of using theclosure device10 illustrated inFIGS. 3A-3B which include a guidewire. As discussed with regard to the method illustrated byFIGS. 4A-4F, the method makes use of asheath52 left in place after a surgical procedure.FIG. 6A illustrates thesheath52 in place in atissue site54 after the surgical procedure.
• As illustrated inFIG. 6B a guidewire82 is inserted into thevessel60 through thesheath lumen64.
• Pressure is applied to theskin56 upstream from thepuncture62 as shown byarrow76 inFIG. 6C to prevent bloodflow through thevessel60. Thesheath52 is then withdrawn from thetissue site54 along the guidewire82 as illustrated byarrow84.
• As illustrated inFIG. 6D, the guidewire82 is then thread within theguidewire lumen48 of theclosure device10 and thedistal end16 is pushed forward through thetissue site54 until theposition sensor30 indicates that theposition sensor30 is within thevessel60. Thedistal end16 of theclosure device10 preferably has the same or larger diameter as the sheath used in the surgical procedure. Since thepuncture62 has been dilated to the diameter of thesheath52, this sizing reduces leakage of blood between thepuncture62 and theclosure device10.
• As illustrated inFIG. 6E, theclosure device10 is slowly withdrawn from thevessel60 until theposition sensor30 indicates that theposition sensor30 is located outside thevessel60. Since theprecursor exit port22 is positioned proximally relative to theposition sensor30, withdrawal of the position sensor from thevessel60 assures that theprecursor exit port22 has been withdrawn from thevessel60.
• As illustrated inFIG. 6F, once theprecursor exit port22 is determined to be outside thevessel60, aclosure composition precursor44 is delivered through theclosure lumen18 and out theprecursor exit port22 adjacent thevessel puncture62.
• FIG. 6G illustrates the complete withdrawal of theclosure device10 from thetissue site54. Pressure is applied at thearrows86 until desired transformation of the fluent closure composition precursor to the non-fluent closure composition is substantially completed.
• Theenergy delivery device28 can be optionally used to deliver a form of energy which functions to accelerate the transformation of the fluent closure composition precursor to non-fluent closure composition. Alternatively or in addition, a catalyst can be added to catalyze the conversion of the fluent precursor to a non-fluent closure composition. Most commonly, energy is used to increase the temperature of the closure composition precursor. In one embodiment, theenergy delivery device28 is a microwave antenna positioned on or within thebody12. The guidewire82 can also include a microwave antenna. When microwave energy is employed, the closure composition precursor preferably includes materials capable of absorbing microwave energy. Examples of such materials include, but are not limited to, hematite (a Fe2O3), maghemite (y-Fe2O3), magnetite (Fe3O4), geothite (□-FeOOH), lepidocrocite (y-FeOOH) ferrihydrite, feroxyhyte (δ-FeOOH), akageneite (β-FeOOH) graphite and amorphous carbon.
• Theenergy delivery device28 may also be awave guide88 for delivery of UV, visible light or laser energy as illustrated inFIG. 7A. Theclosure device10 includes awaveguide collar90.FIG. 7B illustrates a cross section of thewaveguide collar90. A plurality ofwaveguides88 are arranged circumferentially around the collar. The light is provided to thewaveguides88 through acable92 coupled to a light source94.
• Theenergy delivery device28 may also be an electrode for delivering RF energy. The electrode can be a ring electrode encircling thebody12 as illustrated inFIG. 1A or a more localized electrode as illustrated inFIG. 2. The RF supply wires are run through thebody12 and coupled to the energysource attachment port30. Alternatively, RF energy may be delivered to the closure composition precursor via the guidewire82. Other types ofenergy10 can also be used, including those that deliver ultrasound, resistive heating, exothermic chemical heating, other forms of electromagnetic radiation, and frictional heating.
• Referring again toFIG. 1A, one example of aposition sensing mechanism34 is a pressure port coupled to the position monitorattachment port38 by a position lumen. The position monitor40 is a pressure sensor coupled to the position sensor attachment port by tubing. As a result, an open channel is created between the pressure port and the pressure sensor allowing the pressure sensor to detect the pressure at the port. The pressure within thevessel60 is elevated compared with the pressure in the surrounding tissue. As a result, the signal from the pressure sensor indicates whether the position port is located within or outside thevessel60.
• Theposition sensing mechanism34 can also be a contact switch96 as illustrated inFIGS. 8A and 8B. The contact switch is coupled to the position monitorattachment port38 by wires run through the body (not shown). When the switch96 is in contact with the vessel wall the switch96 closes and a circuit (not shown) is completed, however, when the switch96 is not in contact with the vessel wall, the switch96 remains open and the circuit is not completed. The circuit is monitored to determine the position of theclosure device10 relative to thevessel60. Alternatively, the circuit can be coupled to theenergy delivery device24 such that the energy cannot be delivered unless the circuit is completed. In one embodiment, the device includes a mechanism which prevents the closure composition from being delivered if the position sensor is sensed to be within the vessel. As a result, energy will not be delivered unless theclosure device10 is properly positioned within thetissue site54.
• In a preferred embodiment, theclosure device10 includes two or more position sensors positioned around theclosure device10 where a reading that the sensor is outside the vessel occurs when all of the sensors are outside of the vessel. By having more than one position sensor around theclosure device10, false readings from one of the position sensors are reduced or avoided. For instance, if a singleposition sensing mechanism34 is used, the sensing mechanism may become pressed against the vessel wall resulting in a pressure drop at theposition sensing mechanism34. The position monitor40 would falsely provide a signal indicating that theposition sensing mechanism34 is outside thevessel60. When a second position sensing mechanism is included, the second position sensing mechanism would still be exposed to the pressure within thevessel60. As a result, the position monitor40 would not provide a false signal.FIGS. 9A and 9B illustrate aclosure device10 with two position sensing mechanisms. InFIG. 9A, two pressure ports are coupled to a single position lumen. InFIG. 9B, each pressure port is coupled to a separate position lumen but both position lumens are coupled to the same tubing before the tubing is coupled to the pressure sensor.
• FIG. 9C illustrates another embodiment of theclosure device10 according to the present invention. Theclosure device10 includes a plurality ofpressure ports34 and a firstclosure composition port20 and a secondprecursor entrance port46. Anenergy delivery port30 is coupled to a plurality ofenergy delivery devices28. Theclosure device10 includes aguidewire lumen48 for use with the method described inFIG. 6A-6G.
• When theposition sensing mechanism34 is a contact switch or a pressure port, theposition sensing mechanism34 is preferably positioned at least 25 mm from thedistal end16. This positioning assures that thedistal end16 of theclosure device10 remains within thevessel60 when the closure device is positioned to deliver the closure composition precursor. This feature reduces the risk of delivering the closure composition precursor to an improper location on the vessel or within the vessel.
• FIGS. 10A and 10B illustrate anotherposition sensing mechanism34. Aballoon98 is coupled to thedistal end16 of theclosure device10 by a first and second retaining collar99. The balloon is positioned over aninflation port100. The balloon is coupled to aninflation bulb102 by aninflation lumen104 and aninflation tube106. Theballoon98 is deflated when theclosure device10 is positioned within thevessel60. Once theballoon98 enters thevessel60, theballoon98 is inflated to a diameter greater than the diameter of thesheath52 and thus thepuncture62. Theclosure device10 is then withdrawn until the resistance of the balloon against thepuncture62 is felt as illustrated inFIG. 108. The resistance indicates that theprecursor exit port22 is outside thevessel60 and properly positioned for application of the closure composition precursor.
• FIG. 11 illustrates yet another embodiment of aposition sensing mechanism34. According to this embodiment, acurved wire89 is positioned within the vessel. As the vessel is withdrawn, resistance is felt when the curved wire is pushed up against the interior of the vessel lumen. The closure precomposition ports are positioned such that when the resistance is felt, the precomposition ports are known to be positioned outside of the vessel.
• Eachposition sensing mechanism34 can be distally positioned 0.5-30 mm from theprecursor exit port22 and more preferably 3.0-9.0 mm from theprecursor exit port22. These distances allow the closure composition precursor to be reliably delivered outside thevessel60 once theclosure device10 is positioned for delivery of the closure composition precursor.
• A variety of additional sensors may be used in combination with the present invention. For example, temperature sensors may be positioned adjacent thedistal end16 of theclosure device10 for detecting the temperature adjacent thedistal end16. The temperature sensors may be a thermocouple positioned on the surface of the body12 (not shown) and hardwired to electrical contacts within a sensor monitor attachment port (not shown). These sensors are useful for regulating the amount of energy being delivered to thevessel60 and tissue adjacent theclosure device10 and for preventing tissue damage and ablation due to excess heat application.
• Impedance sensors may also be employed when RF is used in order to monitor the amount of energy being delivered to the tissue.
• When the closure composition precursor is formed of two or more components, theclosure device10 can optionally include astatic mixer108 for mixing different closure composition precursor components before the closure composition precursors exit the precursor exit port orports22.FIG. 12A illustrates astatic mixer108 incorporated into theclosure device10. Thefirst closure lumen18 and thesecond closure lumen42 intersect at least one time before terminating in at least oneprecursor exit port22. The static mixer can also be acartridge110 incorporated into thebody12 of theclosure device10 as illustrated inFIG. 12B. The intersection of the first and second lumens assures that the first and second closure composition precursors are mixed before reaching the at least oneprecursor exit port22.
• The configuration of precursor exit ports can also serve to assure adequate mixing of the first and second closure composition precursors. As illustrated inFIG. 13, theprecursor exit ports22 corresponding to the first closure composition alternate with the precursor exit ports corresponding with thesecond closure composition112. As a result, the first and second closure composition precursors are mixed outside theclosure device10.
• Abackflow valve26 which is suitable for use in a closure lumen is illustrated inFIGS. 14A and 14B. Thevalve26 has acomposition entrance114 and a composition exit116.FIG. 14A illustrates that when a fluid flows from theentrance114 to the exit116, adiaphragm118 slides forward to allow the closure composition precursor to flow freely through thevalve26.FIG. 14B illustrates that when a fluid flows from the exit116 to theentrance114, the fluid places pressure against the backside of thediaphragm118 causing thediaphragm118 to slide against theentrance114 sealing theentrance114 and preventing a flow of fluid through thevalve26.
• An example of asuitable backflow valve50 for use in thecentral lumen48 adjacent the distal end of the device is aflapper valve120 as illustrated inFIGS. 15A and 15B. Examples of backflow valves for the central lumen which may be positioned adjacent the proximal end of the device include, but are not limited to, duckbill valves, hemostasis valves, and Tuhoy-Bourse valves. Theflapper valve120 is preferably formed of an elastomeric material such as medical grade silicone rubber. The configuration, as illustrated byFIG. 15B, may be a cylindrical section transitioning into a conical portion. The conical portion has a series ofslits122 which allow various implements to pass through thevalve50. The thickness of theflaps124 and the flexibility of the elastomeric material will be balanced to provide memory sufficient to close the puncture as the implements are withdrawn and provide a fluid seal. Blood pressure against the outer surface of the cone will cause theflapper valve50 to close more tightly.
• Thebody12 is formed of any suitable, relatively flexible material. Suitable materials include, but are not limited to, polyethylene, PEBAX polytetrafluroethylene (TEFLON) and polyurethane.
• A variety of different closure composition precursors and non-fluent closure compositions can be used in the present invention. The fluent closure composition precursor and non-fluent closure composition should be biocompatible and preferably bioresorbable. The closure composition should be also capable of forming a strong puncture seal and be able to seal larger sized vessel punctures, e.g., punctures formed by 8 french or larger needles. Examples of closure compositions that can be used with the device and method of the present include, but are not limited to sealants and adhesives produced by Protein Polymer Technology (Ethicon); FOCALSEAL produced by Focal; BERIPLAST produced by Centeon (JV Behringwerke & Armour); VIVOSTAT produced by ConvaTec (Bristol-Meyers-Squibb); SEALAGEN produced by Baxter; FIBRX produced by CyoLife; TISSEEL AND TISSUCOL produced by immuno AG; QUIXIL produced by Omrix Biopharm; a PEGcollagen conjugate produced by Cohesion (Collagen); HYSTOACRYL BLUE produced by Davis & Geck; NEXACRY, NEXABOND, NEXABOND S/C, and TRAUMASEAL produced by Closure Medical (TriPoint Medical); OCTYL CNA produced by Dermabond (Ethicon); TISSUEGLU produced by Medi-West Pharma; and VETBOND produced by 3M. Examples of two part closure compositions which may be used are listed in Table 1.

  CLASS OF
  ADHESIVE	PART A	PART B
  (Meth) Acrylic	(Meth)acrylic functional	(Meth)acrylic
  (redox initiated)	monomers and oligomers	functional monomers
  	with oxidant initator	and oligomers with
  		reductant initator
  Polyurethane	Poly isocyanate	Hydrocarbon polyol,
  		polyether polyol,
  		polyester polyol
  Polyurea	Poly isocyanate	Hydrocarbon polyamine,
  		polyether polyamine
  Ionomer	Polyvalent metal cation	Acrylic acid
  		(co)polymer, alginate
  Epoxy	Epoxy resin	Aliphatic polyamine,
  		catalyst

• While the present invention is disclosed by reference to the preferred embodiments and examples detailed above, it is to be understood that these examples are intended in an illustrative rather than limiting sense, as it is contemplated that modifications will readily occur to those skilled in the art, which modifications will be within the spirit of the invention and the scope of the appended claims.

Claims (1)

1. An assembly for introducing a closure material to seal a vessel puncture site, the closure material comprising a mixture of a first and second fluid composition which, upon mixing, react to form a nonfluent closure composition, the assembly comprising

a catheter for passage through a tissue puncture and having a distal end, at least one fluid delivery port adjacent the catheter distal end to occupy a position adjacent the vessel puncture site, and a lumen in the catheter in fluid communication with the fluid delivery port,

one or more dispensers in fluid communication with the catheter lumen for dispensing the first and second fluid compositions in the catheter lumen, and

an actuator for causing the first and second fluid compositions to be dispensed from the one or more dispensers mixed by flowing the first and second fluid compositions through a static mixer incorporated in the catheter and dispensed from the fluid delivery port as a fluid mixture that reacts in situ to form the nonfluent closure composition adjacent the vessel puncture site,

wherein the catheter is sized to block flow of the fluid mixture from the fluid delivery port into a substantial part of the tissue puncture, whereby a localized in situ closure forms adjacent the vessel puncture site to seal the vessel puncture site.

Images